earnings
RN
NASDAQ · RNXT
RenovoRx, Inc.
Healthcare · Biotechnology
$1.73
Down-$0.05 (-2.60%)
Updated Sep 18, 2026, 5:09 PM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 36.39M
- P/E ratio
- -3.41
- Dividend yield
- 0.00%
- 52-week range
- $0.77 – $2.59
- Volume
- 636.08K
- Avg. volume
- 506.07K
Price performance
RNXT price history
1M range · 20 trading sessions · Daily adjusted prices
RNXT closed at $1.73 after 20 trading sessions, up 31.06% for the selected period.
- Last close
- $1.73
- Period change
- +31.06%
- Period low
- $1.25
- Period high
- $2.52
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $1.60 | $1.77 | $1.58 | $1.73 | 636.08K |
| Sep 16, 2026 | $1.73 | $1.73 | $1.55 | $1.55 | 1.04M |
| Sep 15, 2026 | $1.692 | $1.73 | $1.60 | $1.72 | 1.03M |
| Sep 14, 2026 | $1.75 | $1.85 | $1.66 | $1.69 | 579.67K |
| Sep 11, 2026 | $1.77 | $1.8199 | $1.67 | $1.76 | 1.17M |
| Sep 10, 2026 | $1.97 | $1.99 | $1.71 | $1.77 | 1.64M |
| Sep 9, 2026 | $2.15 | $2.30 | $1.935 | $1.995 | 1.73M |
| Sep 8, 2026 | $2.31 | $2.345 | $2.1509 | $2.20 | 1.21M |
| Sep 4, 2026 | $2.35 | $2.5396 | $2.28 | $2.39 | 2.09M |
| Sep 3, 2026 | $2.52 | $2.52 | $1.98 | $2.37 | 3.83M |
| Sep 2, 2026 | $2.14 | $2.59 | $2.14 | $2.52 | 4.13M |
| Sep 1, 2026 | $1.91 | $2.20 | $1.83 | $2.11 | 3.31M |
| Aug 31, 2026 | $1.735 | $1.97 | $1.65 | $1.93 | 3.29M |
| Aug 28, 2026 | $1.48 | $1.6788 | $1.4705 | $1.67 | 1.05M |
| Aug 27, 2026 | $1.47 | $1.55 | $1.43 | $1.48 | 428.93K |
| Aug 26, 2026 | $1.41 | $1.55 | $1.3847 | $1.49 | 763.83K |
| Aug 25, 2026 | $1.30 | $1.56 | $1.27 | $1.42 | 1.35M |
| Aug 24, 2026 | $1.33 | $1.3581 | $1.24 | $1.25 | 264.05K |
| Aug 21, 2026 | $1.30 | $1.325 | $1.25 | $1.32 | 233.27K |
| Aug 20, 2026 | $1.29 | $1.35 | $1.23 | $1.32 | 381.18K |
Latest RNXT news
The latest Smart Investors Daily articles mentioning RNXT.
Stock researchResearch & News · SID Coverage
Loading stock research…